Skip to content

TRAVEL PHARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

TRAVEL PHARMA

BE 0644.400.989
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€30,350
2024 · -€11,862+€42,212
Equity
-€9,903
2024 · -€40,253+€30,350
Cash
€185
2024 · €39+€146
Balance sheet total
€90,536
2024 · €24,292+€66,244

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€71,529

    up €71,529 (+1,247%), from €5,736 to €77,265

    of which Other amounts receivable: +€70,667

  • Intangible fixed assets -€6,063

    down €6,063 (-40.0%), from €15,147 to €9,084

Equity and liabilities
  • Profit (loss) carried forward +€30,350

    up €30,350 (+51.6%), from -€58,863 to -€28,513

  • Other debts +€16,412

    up €16,412 (+28.1%), from €58,430 to €74,842

  • Tax, wage and social debts +€12,794

    up €12,794, from €0 to €12,794

  • Trade debts +€4,791

    up €4,791 (+101%), from €4,764 to €9,554

  • Accrued charges and deferred income +€1,897

    up €1,897 (+140%), from €1,351 to €3,248

Income statement
  • Gross operating margin +€43,381

    up €43,381, from -€1,984 to €41,397

  • Financial charges +€2,412

    up €2,412 (+92.7%), from €2,603 to €5,015

  • Financial income +€639

    up €639 (+418%), from €153 to €792

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€11,862
Gross operating margin +€43,381
Depreciation +€354
Other operating charges +€250
Financial income +€639
Financial charges -€2,412
Result 2025 €30,350
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€146
Investment €0
Financing €0
Cash 2024 €39
Net result for the year +€30,350
Depreciation +€6,063
Receivables within one year -€71,529
Deferred charges and accrued income -€631
Trade debts +€4,791
Tax, wage and social debts +€12,794
Other debts +€16,412
Accrued charges and deferred income +€1,897
Cash 2025 €185
brings cash intakes cash out
Every line side by side 37 lines
Line Code 2024 2025 Change %
Total assets 20/58 €24,292 €90,536 +€66,244 +273%
Fixed assets 21/28 €15,147 €9,084 -€6,063 -40.0%
Intangible fixed assets 21 €15,147 €9,084 -€6,063 -40.0%
Current assets 29/58 €9,145 €81,452 +€72,307 +791%
Stocks and contracts in progress 3 €3,217 €3,217 = 0.0%
Stocks 30/36 €3,217 €3,217 = 0.0%
Amounts receivable within one year 40/41 €5,736 €77,265 +€71,529 +1,247%
Trade receivables 40 €4,361 €5,223 +€862 +19.8%
Other amounts receivable 41 €1,375 €72,042 +€70,667 +5,139%
Cash at bank and in hand 54/58 €39 €185 +€146 +378%
Deferred charges and accrued income 490/1 €153 €784 +€631 +413%
Total equity and liabilities 10/49 €24,292 €90,536 +€66,244 +273%
Equity 10/15 -€40,253 -€9,903 +€30,350 +75.4%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €10 €10 = 0.0%
Non-distributable reserves 130/1 €10 €10 = 0.0%
Other 1319 €10 €10 = 0.0%
Profit (loss) carried forward 14 -€58,863 -€28,513 +€30,350 +51.6%
Amounts payable 17/49 €64,545 €100,439 +€35,894 +55.6%
Amounts payable within one year 42/48 €63,194 €97,191 +€33,997 +53.8%
Trade debts 44 €4,764 €9,554 +€4,791 +101%
Suppliers 440/4 €4,764 €9,554 +€4,791 +101%
Taxes, remuneration and social security 45 €0 €12,794 +€12,794
Taxes 450/3 €0 €12,794 +€12,794
Other amounts payable 47/48 €58,430 €74,842 +€16,412 +28.1%
Accrued charges and deferred income 492/3 €1,351 €3,248 +€1,897 +140%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €6,417 €6,063 -€354 -5.5%
Other operating charges 640/8 €1,011 €761 -€250 -24.7%
Gross operating margin 9900 -€1,984 €41,397 +€43,381
Operating profit (loss) 9901 -€9,412 €34,573 +€43,985
Financial income 75/76B €153 €792 +€639 +418%
Recurring financial income 75 €153 €792 +€639 +418%
Financial charges 65/66B €2,603 €5,015 +€2,412 +92.7%
Recurring financial charges 65 €2,603 €5,015 +€2,412 +92.7%
Profit (loss) for the period before taxes 9903 -€11,862 €30,350 +€42,212
Profit (loss) for the period 9904 -€11,862 €30,350 +€42,212
Profit (loss) for the period to be appropriated 9905 -€11,862 €30,350 +€42,212

Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.